OK-432 therapy for lymphangioma in children

Jornal de Pediatria

Volumn 80, Issue 2, 2004, Pages 154-158

  Ruiz Jr , Everaldo ^a   Valera, Elvis T ^a   Veríssimo, Francisco ^a   Tone, Luiz G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Children; Lymphangiomas; OK 432; Sclerosing agents

Indexed keywords

ALPHA INTERFERON; AMINOCAPROIC ACID; PICIBANIL; PREDNISONE; ANTINEOPLASTIC AGENT;

ARTICLE; BRAZIL; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG RESPONSE; ERYTHEMA; FEMALE; HUMAN; INFANT; INFLAMMATION; LYMPHANGIOMA; MALE; NEWBORN; RETROSPECTIVE STUDY; SCAR FORMATION; SKIN DEFECT; TONGUE EDEMA; TUMOR VOLUME; FOLLOW UP; HEAD AND NECK TUMOR; PRESCHOOL CHILD;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INFANT; INFANT, NEWBORN; LYMPHANGIOMA; PICIBANIL; RETROSPECTIVE STUDIES;

EID: 16544393570     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/1156     Document Type: Article

References (13)

1. Smith RJH, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM. OK 432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg. 1996;122:1195-9.
2. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK 432 therapy in 64 patients with lymphangioma. J Pediatr Surg. 1994;29(6):784-5.
3. Schmidt B, Schimpt G, Höllwarth ME. OK 432 therapy of lymphangiomas in children. Eur J Pediatr. 1996;155:649-52.
4. Molich HI, Unger EC, Witte CL, van Sonnenberg E. Percutaneous sclerotherapy of lymphangiomas. Radiology. 1995;194:343-7.
5. Giguere CM, Bauman NM, Smith RJ. New treatment options for lymphangioma in infants and children. Ann Otol Rhinol Laryngol. 2002;111(12 Pt 1):1066-75.
6. Souza RJSP, Tone LG. Tratamento clínico do linfangioma com alfa-2a-interferon. J Pediatr (Rio J). 2001;77(2):139-42.
7. Giguere CM, Bauman NM, Sato Y, Burke DK, Greinwald JH, Pranskelley P, et al. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg. 2002;128(10):1137-44.
8. Sanlialp I, Karnak I, Tanyel FC, Senocak ME, Buyukpamukcu N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol. 2003;67(7):795-800.
9. Ishida N, Hoshino T. A streptococcal preparation as a potent biological response modifier OK 432. 2nd ed. Amsterdam: Excerpta Medica; 1985.
10. Rautio R, Keski-Nisula L, Laranne J, Laasonen E. Treatment of lymphangiomas with OK-432 (Pincibanil). Cardiovasc Intervent Radiol. 2003;26(1):31-6.
11. Tyota B. Clinical effects of a streptococcal preparation, OK 432, against head and neck cancers. Jpn J Otol. 1967;72:1332-8.
12. Ogita S, Tsuto T, Tokiwa K, Takashi T: Intracystic injection of OK 432: a new sclerosing therapy for cystic hygroma in children. Br J Surg. 1987;74:690-1.
13. Hall N, Ade-Ajayi N, Brewis C, Roebuck DJ, Kiely EM, Drake DP, et al. Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? Surgery. 2003;133(3):238-42.